title: Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?
authors.affiliation: Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK.
authors.forename: J B
authors.initials: JB
authors.lastname: Lilleker
authors.affiliation: Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK.
authors.forename: E A
authors.initials: EA
authors.lastname: Lim
authors.affiliation: Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
authors.forename: M
authors.initials: M
authors.lastname: Jones
authors.affiliation: Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
authors.forename: A M T
authors.initials: AM
authors.lastname: Richardson
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D020275:Guillain-Barre Syndrome / Q000150:complications*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies; D014139:Tracheostomy / Q000009:adverse effects; D054556:Venous Thromboembolism / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006493:Heparin
keywords: GUILLAIN-BARRE SYNDROME; INTENSIVE CARE; NEUROMUSCULAR